Sino Biological,Inc. (SZSE: 301047)
Health Care · Biotechnology · CN
CN¥118.80
-8.72% today · +60.2% 1Y
Sino Biological,Inc. (SZSE: 301047) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.15B.
Over the last twelve months the share price has gained 60.2%, trading between 58.05 and 139.49.
Tweenvest scores Sino Biological,Inc. across four factors: quality 68/100, value 29/100, growth 32/100, dividend 90/100. Its strongest factor is dividend.
301047 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.15B
- Revenue (TTM)
- $105.50M
- P/E
- 91.89
- EPS
- 1.29
- Dividend yield
- 4.38%
- Beta (5Y)
- 0.69
- 52-week high
- CN¥139.49
- 52-week low
- CN¥58.05
- Avg volume (3M)
- —
- Shares outstanding
- 121.64M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.